SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending after being selected for inclusion in the S&P 500 index, a move investors expect to generate significant demand from index-tracking funds. The announcement has sparked a mix of enthusiasm over potential price gains and debate regarding whether the move is a long-term catalyst or a short-term 'sell-the-news' event similar to other recent index additions.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently trading near 52-week lows, fueling intense debate between traders viewing the decline as a generational buying opportunity for a blue-chip dividend stock and bears who argue the company is struggling with poor brand perception, declining consumer traffic, and a lack of competitive menu value. While many participants express confidence in the firm's real estate value and long-term stability, others contend that the stock remains in a persistent downtrend as consumer discretionary spending softens.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is experiencing significant upward price momentum driven by strong buying volume and a community sentiment that favors its privacy-focused technology as a potential alternative to Bitcoin. Traders are also citing excitement over the potential for increased institutional exposure and the company's limited circulating supply as key catalysts for the recent price rally.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is trending as investors rotate back into semiconductor equipment stocks following a broad sector recovery from recent selloffs. The community highlights the company's strong position in process-control technology and resilient demand for AI-driven chip infrastructure, despite ongoing concerns regarding valuation and exposure to U.S. export restrictions in China.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh an expanded AI infrastructure partnership with Hewlett Packard Enterprise against broader market volatility ahead of the upcoming earnings report. While some traders express frustration with the recent price decline, others are maintaining a bullish outlook, viewing the stock as undervalued given its massive cloud infrastructure backlog.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy shares are being driven by increased volatility and community attention surrounding the escalating geopolitical conflict in the Middle East, particularly reports of damage to natural gas infrastructure in Qatar. Traders are actively debating whether these supply disruptions create a structural long-term tailwind for U.S. LNG exporters or if the volatility is primarily driven by speculative overreaction to energy sector news.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and attention following its listing on the Upbit exchange, which traders are linking to a sharp spike in trading volume. While some participants are optimistic about potential price appreciation and infrastructure developments, others are dismissing the move as a typical pump-and-dump scheme, citing historical price patterns.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

DIA is trending primarily due to investor focus on the Federal Reserve's path for interest rates, with the conversation dominated by strong August jobs data and speculation about potential rate hikes. The community remains divided, with many traders debating the Fed's next moves while expressing uncertainty regarding the broader economic landscape and regional geopolitical tensions.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen shares are trending following the FDA approval of IMDELLTRA for the treatment of small cell lung cancer, marking a key milestone for its oncology portfolio. Traders are also actively discussing the company's cardiometabolic pipeline and its role as a potential M&A player in the obesity drug space.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending as investors focus on its pivot from Bitcoin mining to AI data center infrastructure, bolstered by a significant 16-year, $4.7 billion lease for its Norway facility. While enthusiasm is high regarding the company's vertically integrated business model and potential hyperscaler deals, some traders express frustration with recent price volatility and skepticism regarding the timing of contract signatures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Bessemer is swimming against the PE tide in Indian healthcare

… hospital chains and the broader healthcare provider sector. Central to Bessemer … cumulative PE investment in offline healthcare providers at $10.6 billion … such as Apollo Hospitals, Max Healthcare , Fortis Healthcare , Narayana Hrudayalaya, and others …

Narayana Hrudayalaya Forms Wholly Owned Subsidiary to Drive Northern India Expansion

Narayana Hrudayalaya Ltd. ( ($IN:NH) ) just unveiled an update. Narayana Hrudayalaya Ltd. has incorporated a new wholly owned subsidiary, Narayana ...

Brief Healthcare: ORMP: Advancing Clinical Activities and more

In this briefing: ORMP: Advancing Clinical Activities RVPH: Brilaroxazine Poster Presentations WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader 1. ORMP: Advancing Clinical Activities ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has substantial liquidity as it both advances its oral drug delivery platform and pursues strategic opportunities, including strategic investments. The company received ~$27m on its Scilex investment in 3Q25, with the principal on the Scilex investment now fully repaid. 2. RVPH: Brilaroxazine Poster Presentations Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications. The candidates address multiple related mental disorders, rare diseases & other categories of un met need.

Brief Healthcare: RVPH: Brilaroxazine Poster Presentations and more

In this briefing: RVPH: Brilaroxazine Poster Presentations WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader Monash IVF (MVF AU) Rejects Soul Patts/Genesis' Offer 1. RVPH: Brilaroxazine Poster Presentations Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications. The candidates address multiple related mental disorders, rare diseases & other categories of un met need. Reviva's lead indication in schizophrenia with brilaroxazine completed its Phase III RECOVER trial & may pursue future studies. 2. WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Key takeaways from 3Q25 earnings release. Lu highlighted Ainos’ strong revenue momentum, up more than 4x Y/Y, driven almost entirely by the deployment of AI Nose in senior care programs.

Brief Healthcare: WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 and more

In this briefing: WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion UltraGreen.ai IPO: High Growth and High Margins, Market Leader Monash IVF (MVF AU) Rejects Soul Patts/Genesis' Offer Madrigal Pharma: Inside the MAESTRO-NASH Breakthrough- How Weight Loss Supercharges Antifibrotic Effects! 1. WTR Small-Cap Spotlight Recap: AI Nose's Continuing Momentum in 2025 and What to Expect in 2026 Key takeaways from 3Q25 earnings release. Lu highlighted Ainos’ strong revenue momentum, up more than 4x Y/Y, driven almost entirely by the deployment of AI Nose in senior care programs. Lu noted that the reported revenue has yet to include any of the $2.1-million, three-year AI Nose subscription order from a semiconductor customer, signaling additional upside in the SmellTech platform’s revenue, the turnaround in gross margin to 82% YTD from negative last year, and Ainos’ cost management with cash operating expenses reduced by 15% YTD versus the previous year.

Narayana Hrudayalaya shares climb 10% as Q2 net profit rises 30% to Rs 258.3 crore

Narayana Hrudayalaya shares saw a significant jump following strong quarterly results. The healthcare chain reported robust growth in revenue and profit for the September quarter. Both Indian and Cayman Islands operations contributed to this impressive performance. The company's net profit and operating revenue increased substantially year-on-year. This positive financial update has boosted investor confidence.

Narayana Hrudayalaya share price jumps over 7% on strong Q2 results; India, Cayman revenues highest ever

Narayana Hrudayalaya's share price rose over 7% after reporting record revenue and profitability for Q2FY26, with a net profit surge of 29.6% to ₹258 crore. Consolidated operating revenue increased by 20.3% to ₹1643.8 crore, driven by strong performance in both India and Cayman businesses.

Hospitals Get Pricing Relief: Fortis, Apollo, Max Healthcare Gain After Government Revises Rates For Nearly 2,000 Procedures

Equity

The CGHS revamp addresses long-standing concerns from private hospitals that earlier packages were outdated and failed to reflect rising medical costs

Narayana Hrudayalaya Faces Five Technical Red Flags: SEBI RA Warns Of An Overstretched Rally 

The stock has surged nearly 65% in 2025, but the analyst highlights a buildup of risk factors that could trigger a near-term correction.

Healthcare firm Narayana Hrudayalaya acquires prime land parcels in Bengaluru for ₹246 crore

Healthcare company Narayana Hrudayalaya Limited has … to documents accessed by Propstack. Healthcare company Narayana Hrudayalaya Limited has … along Bannerghatta Road, a prominent healthcare and residential corridor in south …

Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. It also provides services in the areas of cardiac surgery, cardiology, diabetes and endocrinology, gastroenterology, general surgery, neurosciences, facial surgery, nephrology, obstetrics and gynecology, orthopedics, oncology, pediatrics, transplant, urology, and vascular surgery; and other specialty services, such as dental, dermatology, emergency medicine, ears, nose, and throat, family medicine, general medicine, and genetic. The company was founded by Devi Prasad Shetty on July 19, 2000 and is headquartered in Bangalore, India.

Current Price	1,862.00
Prev Close	1,885.50
Open	1,881.00
Dividend Yield	0.28%
50-Day Moving Average	1,938.28
Beta	N/A
Avg. Volume	389,989.38
PE Ratio	46.25

52-Week High	2,093.30
52-Week Low	1,589.00
Market Capitalization	384.39B
EPS (Annual)	39.67
Price to Book	8.32
Revenue Per Employee	5.11M

Feed

News

Sentiment

Fundamentals

Info

NH.NSE Fundamentals